On December 29, 2020, Green Valley Pharmaceuticals celebrated the 1st Anniversary of GV-971 China Launch and 2nd Gut-Brain Axis Forum in a virtual form, which was attended online by more than 3,000 experts, scholars and clinicians from across China. The event explored the pathogenesis of Alzheimer's disease (AD) from a brand-new perspective, providing new direction for AD treatment and research and bringing new hope to more patients and families.